Bath & Body Works $6.96: raises FY2026 adjusted EPS and narrows sales guidance
Bath & Body Works raised FY2026 adjusted EPS guidance to $2.60-$2.80 from $2.40-$2.65 versus a $2.65 analyst estimate and narrowed FY2026 sales to $6.999B-$7.109B versus $7.095B.
Bath & Body Works (NYSE: BBWI ) raises FY2026 Adj EPS guidance from $2.40-$2.65 to $2.60-$2.80 vs $2.65 analyst estimate.
Narrows FY2026 sales outlook from $6.963 billion-$7.109 billion to $6.999 billion-$7.109 billion vs $7.095 billion estimate.